Oxytocin as a Biomarker of Differential Effects to SPACE vs. CBT Treatment of Child Anxiety Disorders
Zilcha-Mano S, Orbach M, Malka M, Lebowitz E. Oxytocin as a Biomarker of Differential Effects to SPACE vs. CBT Treatment of Child Anxiety Disorders. Journal Of Clinical Child & Adolescent Psychology 2023, ahead-of-print: 1-9. PMID: 37166402, PMCID: PMC10638466, DOI: 10.1080/15374416.2023.2188557.Peer-Reviewed Original ResearchSalivary OT levelsLine of researchAnxiety treatmentPositive mother-child interactionsChild anxiety treatmentChild anxiety disordersChildhood anxiety treatmentMother-child interactionMother-child dyadsHigher baseline levelsChildhood anxietyCBT treatmentGreater treatment efficacyDyadic interactionsAnxiety disordersTarget of treatmentOutcome moderatorsDisorder ScalePeripheral oxytocinEmotional Disorders (SCARED) scaleOT levelsNovel treatment targetsCBTModeratorMixed results